Alternative methods in toxicology: CFU assays application, limitation and future prospective

References

• Abnosi MH, Jafari Yazdi Z. (2012). Low dose and long term toxicity of sodium arsenite caused caspase dependent apoptosis based on morphology and biochemical character. Cell J 14:161–170
   PubMed Web of Science ®Google Scholar
• Akiyama K, You YO, Yamaza T, et al. (2012). Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther 3:1–13
   PubMed Web of Science ®Google Scholar
• Attar EC, Scadden DT. (2004). Regulation of hematopoietic stem cell growth. Leukemia 18:1760–1768
   PubMed Web of Science ®Google Scholar
• Axelrod AA, McLeod OL, Shreeve MM, Heath DS. (1973). Properties of cells that produce erythrocitic colonies in vitro. In: Robinson AW, ed. Proceedings of the second international workshop on haemopoiesis in culture. New York: Grune and Stratton, 226–234
   Google Scholar
• Balls M, Blaauboer BJ, Fentem JH, et al. (1995). Practical aspects of the validation of toxicity test procedures – the report and recommendations of Ecvam Workshop-5. ATLA-Alternatives Lab Anim 23:129–147
   Web of Science ®Google Scholar
• Belle L, Bruck F, Foguenne J, et al. (2012). Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells. PLoS One 7:e(5256)4
   Web of Science ®Google Scholar
• Bhatia M. (2007). Hematopoietic development from human embryonic stem cells. Hematol Am Soc Hematol Educ Prog 2007:11–16
   Google Scholar
• Brandt J, Briddell RA, Srour EF, et al. (1992). Role of C-Kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79:634–641
   PubMed Web of Science ®Google Scholar
• Bryder D, Jacobsen SE. (2000). Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 96:1748–1755
   PubMed Web of Science ®Google Scholar
• Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641–650
   PubMed Web of Science ®Google Scholar
• Carfi M, Croera C, Ferrario D, et al. (2008). TBTC induces adipocyte differentiation in human bone marrow long term culture. Toxicology 249:11–18
   PubMed Web of Science ®Google Scholar
• Carfi M, Gennari A, Malerba I, et al. (2007). In vitro tests to evaluate immunotoxicity: a preliminary study. Toxicology 229:11–22
   PubMed Web of Science ®Google Scholar
• Casati S, Collotta A, Gribaldo L. (1999). Human umbilical cord blood and bone marrow as a source of CD34+ CD38− cells for the in vitro CFU-MK assay. ATLA-Altern Lab Anim 27:120
   Google Scholar
• Casati S, Collotta A, Clothier R, et al (2003). Refinement of the colony-forming unit-megakaryocyte (CFU-MK) assay for its application to pharmaco-toxicological testing. Toxicol In Vitro 17:69–75
   Google Scholar
• Castro-Malaspina H, Gay Re, Resnick G, et al. (1980). Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289–301
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Basak P, Chaklader M, et al. (2013). Pesticide induced marrow toxicity and effects on marrow cell population and on hematopoietic stroma. Exp Toxicol Pathol 65:287–295
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Dutta RK, Basak P, et al. (2010). Alteration in marrow stromal microenvironment and apoptosis mechanisms involved in aplastic anemia: an animal model to study the possible disease pathology. Stem Cells Int 2010:Article ID 932354, doi:10.4061/2010/932354
   Google Scholar
• Clarke E, Pereira C, Chaney R, et al. (2007). Toxicity testing using hematopoietic stem cell assays. Regen Med 2:947–956
   PubMed Web of Science ®Google Scholar
• Croera C, Ferrario D, Gribaldo L. (2008). In vitro toxicity of naphthalene, 1-naphthol, 2-naphthol and 1,4-naphthoquinone on human CFU-GM from female and male cord blood donors. Toxicol In Vitro 22:1555–1561
   PubMed Web of Science ®Google Scholar
• Curren RD, Southee JA, Spielmann H, et al. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA-Altern Lab Anim 23:211–217
   Web of Science ®Google Scholar
• Dal Negro G, Bonato M, Gribaldo L. (2001). In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs. Cell Biol Toxicol 17:95–105
   PubMed Web of Science ®Google Scholar
• Dal Negro G, Vandin L, Bonato M, et al. (2006a). A new experimental protocol as an alternative to the colony-forming unit-granulocyte/macrophage (CFU-GM) clonogenic assay to assess the haematotoxic potential of new drugs. Toxicol In Vitro 20:750–756
   PubMed Web of Science ®Google Scholar
• Dal Negro G, Vandin L, Bonato M, Sciuscio D. (2006b). Toward refinement of the colony-forming unit-granulocyte/macrophage clonogenic assay: inclusion of a metabolic system. Toxicol In Vitro 20:743–749
   PubMed Web of Science ®Google Scholar
• Damen J. (2012). The CFU assay in preclinical toxicity testing: an in vitro tool for predicting in vivo cytopenia. Vancouver, Canada: STEMCELL Technologies Inc
   Google Scholar
• Davies C, Yip BH, Fernandez-Mercado M, et al. (2013). Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34(+) progenitor cells. Brit J Haematol 160:842–850
   PubMed Web of Science ®Google Scholar
• Denker HW. (1999). Embryonic stem cells: an exciting field for basic research and tissue engineering, but also an ethical dilemma? Cells Tissues Organs 165:246–249
   PubMed Web of Science ®Google Scholar
• Denker HW. (2000). Embryonale Stammzellen und ihre ethische Wertigkeit: Aspekte des Totipotenz-Problems. In: Honnefelder LS, ed. Jahrbuch für Wissenschaft und Ethik. Berlin: Walter de Gruyter, 291–304
   Google Scholar
• Denker HW. (2002). Forschung an embryonalen stammzellen: eine diskussion der begriffe totipotenz und pluripotenz. In: Oduncu FSU, Vossenkuhl W, eds. Stammzellenforschung und therapeutisches Klonen. Göttingen: Vandenhoeck und Ruprecht, 19–35
   Google Scholar
• Denker HW. (2009). Induced pluripotent stem cells: how to deal with the developmental potential. Reprod Biomed Online 19:34–37
   PubMed Web of Science ®Google Scholar
• Diodovich C, Bianchi MG, Bowe G, et al. (2004). Response of human cord blood cells to styrene exposure: evaluation of its effects on apoptosis and gene expression by genomic technology. Toxicology 200:145–157
   PubMed Web of Science ®Google Scholar
• Diodovich C, Ferrario D, Casati B, et al. (2005a). Sensitivity of human cord blood cells to tetrachloroethylene: cellular and molecular endpoints. Arch Toxicol 79:508–514
   PubMed Web of Science ®Google Scholar
• Diodovich C, Malerba I, Ferrario D, et al. (2005b). Gene and protein expressions in human cord blood cells after exposure to acrylonitrile. J Biochem Mol Toxicol 19:204–212
   PubMed Web of Science ®Google Scholar
• Erickson-Miller CL, May RD, Tomaszewski J, et al. (1997). Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro. Cancer Chemother Pharmacol 39:467–472
   PubMed Web of Science ®Google Scholar
• Ferrari G, Cusella-De Angelis G, Coletta M, et al. (1998). Muscle regeneration by bone marrow derived myogenic progenitors. Science 279:1528–1530
   PubMed Web of Science ®Google Scholar
• Ferrario D, Croera C, Brustio R, et al. (2008). Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors “in vitro”: comparison between species and sexes. Toxicology 249:102–108
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhyan RK, Gerasimov UV. (1987). Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20:263–272
   PubMedGoogle Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
   PubMedGoogle Scholar
• Friedenstein AJ, Gorskaja JF, Kulagina NN. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol, 4:267–274
   PubMed Web of Science ®Google Scholar
• Froquet R, Sibiril Y, Parent-Massin D. (2001). Improvement of megakaryocytic progenitor culture for toxicological investigations. Toxicol In Vitro 15:691–699
   PubMed Web of Science ®Google Scholar
• Ghielmini M, Colli E, Bosshard G, et al. (1998). Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites. Cancer Chemother Pharmacol 42:235–240
   PubMed Web of Science ®Google Scholar
• Glimm H, Oh IH, Eaves CJ. (2000). Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 96:4185–4193
   PubMed Web of Science ®Google Scholar
• Goff JP, Shields DS, Wang H, et al. (2013). Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells. Exp Hematol 41:957–966
   PubMed Web of Science ®Google Scholar
• Gordon MY. (1993a). Human haemopoietic stem cell assays. Blood Rev 7:190–197
   PubMed Web of Science ®Google Scholar
• Gordon MY. (1993b). Origin and development of neutrophils In Immunopharmacology of neutrophils. London (UK): Academic Press, Ltd
   Google Scholar
• Grande T, Bueren JA. (1995). Analysis of hematopoiesis in mice irradiated with 500 mGy of X rays at different stages of development. Radiat Res 143:327–333
   PubMed Web of Science ®Google Scholar
• Greenwalt DE, Szabo J, Manchel I. (2001). High throughput cell-based assay of hematopoietic progenitor differentiation. J Biomolec Screen 6:383–392
   PubMed Web of Science ®Google Scholar
• Grever MR, Grieshaber CK. (1997). Chapter 59: Toxicology by organ system. In: Holland JF, Frei E, Bast R, et al., eds. Cancer medicine. 4th ed. Philadelphia (PA): Lea and Fibiger, 891–906
   Google Scholar
• Gribaldo L. (2000). Haematotoxicology in drug development: a model of human toxicology. Prog Reduction Refinement Replacement Anim Exp 31:671–677
   Google Scholar
• Gribaldo L, Casati S, Figliuzzi L, Marafante E. (1998). In vitro myelotoxicity of environmental contaminants. Environ Toxicol Pharmacol 6:135–141
   PubMed Web of Science ®Google Scholar
• Gribaldo L, Malerba I, Collotta A, et al. (2000). Inhibition of CFU-E/BFU-E by 3′-azido-3′-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures. Toxicol Sci 58:96–101
   PubMed Web of Science ®Google Scholar
• Haglund C, Aleskog A, Hakansson LD, et al. (2010). The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing. Toxicol Lett 194:102–107
   PubMed Web of Science ®Google Scholar
• Hartmann J, Braulke F, Sinzig U, et al. (2013). Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. Leukemia Res 37:327–332
   PubMed Web of Science ®Google Scholar
• Heinemann T. (2005). Klonieren beim Menschen. Analyse des Methodenspektrums und internationaler Vergleich der ethischen Bewertungskriterien. Berlin: Walter de Gruyter
   Google Scholar
• Holm S. (2004). Stem cell transplantation and ethics: a European overview. Fetal Diagn Ther 19:113–118
   PubMed Web of Science ®Google Scholar
• Holm S. (2005). Embryonic stem cell research and the moral status of human embryos. Reprod Biomed Online 10:63–67
   PubMed Web of Science ®Google Scholar
• Horowitz D, King AG. (2000). Colorimetric determination of inhibition of hematopoietic progenitor cells in soft agar. J Immunol Methods 244:49–58
   PubMed Web of Science ®Google Scholar
• Jing DH, Fonseca AV, Alakel N, et al. (2010). Hematopoietic stem cells in co-culture with mesenchymal stromal cells – modeling the niche compartments in vitro. Haematol Hematol J 95:542–550
   PubMed Web of Science ®Google Scholar
• Kandarova H, Letasiova S. (2011). Alternative methods in toxicology: pre-validated and validated methods. Interdiscip Toxicol 4:107–113
   PubMedGoogle Scholar
• Kang L, Gao S. (2012). Pluripotency of induced pluripotent stem cells. J Anim Sci Biotechnol 3:5
   PubMed Web of Science ®Google Scholar
• Lemischka I. (1991). Clonal, in vivo behavior of the totipotent hematopoietic stem cell. Semin Immunol 3:349–355
   PubMedGoogle Scholar
• Liu YX, Yue W, Ji L, et al. (2010). Production of erythriod cells from human embryonic stem cells by fetal liver cell extract treatment. BMC Dev Biol 10:85. doi:10.1186/1471-213X-10-85
   PubMed Web of Science ®Google Scholar
• Ma F, Wang D, Hanada S, et al. (2007). Novel method for efficient production of multipotential hematopoietic progenitors from human embryonic stem cells. Int J Hematol 85:371–379
   PubMed Web of Science ®Google Scholar
• Malerba I, Casati S, Diodovich C, et al. (2004). Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method. Toxicol In Vitro 18:293–300
   PubMed Web of Science ®Google Scholar
• Malerba I, Castoldi AF, Parent-Massin D, Gribaldo L. (2002). In vitro myelotoxicity of propanil and 3,4-dichloroaniline on murine and human CFU-E/BFU-E progenitors. Toxicol Sci 69:433–438
   PubMed Web of Science ®Google Scholar
• May JE, Morse HR, Xu J, Donaldson C. (2012). Development of a novel, physiologically relevant cytotoxicity model: application to the study of chemotherapeutic damage to mesenchymal stromal cells. Toxicol Appl Pharmacol 263:374–389
   PubMed Web of Science ®Google Scholar
• Mets T, Verdonk G. (1981). In vitro aging of human bone marrow derived stromal cells. Mech Ageing Dev 16:81–89
   PubMed Web of Science ®Google Scholar
• Miller CL, Eaves CJ. (1997). Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability. Proc Natl Acad Sci USA 94:13648–13653
   PubMed Web of Science ®Google Scholar
• Molyneux G, Gibson FM, Chen CM, et al. (2008). The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. Int J Exp Pathol 89:138–158
   PubMed Web of Science ®Google Scholar
• Naughton BA, Naughton GK. (1989). Hematopoiesis on nylon mesh templates. Comparative long-term bone marrow culture and the influence of stromal support cells. Ann N Y Acad Sci 554:125–140
   PubMed Web of Science ®Google Scholar
• Naughton BA, Sibanda B, Azar L, San Roman J. (1992). Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. Proc Soc Exp Biol Med 199:481–490
   PubMed Web of Science ®Google Scholar
• Orlovskaya I, Schraufstatter I, Loring J, Khaldoyanidi S. (2008). Hematopoietic differentiation of embryonic stem cells. Methods 45:159–167
   PubMed Web of Science ®Google Scholar
• Outlook Reports. (2010). Tufts Center for the Study of Drug Development, TUFTS University, Boston, MA, USA, pp. 1–12
   Google Scholar
• Owen ME, Friedenstein AJ. (1998). Stromal stem cells: marrow-derived osteogenic precursors. Cell and molecular biology of vertebrate hard tissues: Ciba Foundation Symposium; Chichester (UK), 42–60
   Google Scholar
• Parchment RE. (1998). Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity. Environ Health Perspect 106:541–557
   PubMed Web of Science ®Google Scholar
• Parchment RE, Gordon M, Grieshaber CK, et al. (1998). Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. Ann Oncol 9:357–364
   PubMed Web of Science ®Google Scholar
• Parchment RE, Volpe DA, Lorusso PM, et al. (1994). In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-(3661)40, PD(1159)34) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow. J Natl Cancer Inst 86:273–280
   PubMed Web of Science ®Google Scholar
• Parent-Massin D. (1997). Improvement of erythroblastic progenitor culture for toxicological investigations. Toxicol Mech Meth 7:363–380
   Google Scholar
• Parent-Massin D. (2000). Relevance of clonogenic assays in food haematotoxicology. In: Balls M, Zeller AM, Halder M, eds. Progress in the reduction, refinement and replacement of animal experimentation, development in animal and veterinary sciences. 3rd, World Congress on Alternatives and Animal Use in the Life Sciences. Elsevier Science, 709–716
   Google Scholar
• Parent-Massin D. (2001). Relevance of clonogenic assays in hematotoxicology. Cell Biol Toxicol 17:87–94
   PubMed Web of Science ®Google Scholar
• Parent-Massin D, Hymery N, Sibiril Y. (2010). Stem cells in myelotoxicity. Toxicology 267:112–117
   PubMed Web of Science ®Google Scholar
• Parent-Massin D, Thouvenot D. (1993). In vitro study of pesticide hematotoxicity in human and rat progenitors. J Pharmacol Toxicol Methods 30:203–207
   PubMed Web of Science ®Google Scholar
• Pereira C, Clarke E, Damen J. (2007). Hematopoietic colony-forming cell assays. Methods Mol Biol 407:177–208
   Google Scholar
• Pereira RF, O'Hara MD, Laptev AV, et al. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci USA 95:1142–1147
   PubMed Web of Science ®Google Scholar
• Pessina A, Albella B, Bayo M, et al. (2002). In vitro tests for haematotoxicity: prediction of drug-induced myelosuppression by the CFU-GM assay. Altern Lab Anim 30:75–79
   PubMed Web of Science ®Google Scholar
• Pessina A, Albella B, Bayo M, et al. (2003). Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics. Toxicol Sci 75:355–367
   PubMed Web of Science ®Google Scholar
• Pessina A, Albella B, Bueren J, et al. (2001). Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol In Vitro 15:729–740
   PubMed Web of Science ®Google Scholar
• Pessina A, Bonomi A. (2007). CFU-GM assay for evaluation of drug myelotoxic activity. In: Maines MD, ed. Current protocols in toxicology. Chapter 20. John Wiley and Sons Inc., Unit 20.2
   Google Scholar
• Pessina A, Bonomi A, Baglio C, et al. (2009a). Refinement and optimisation of the rat CFU-GM assay to incorporate the use of cryopreserved bone-marrow cells for in vitro toxicology applications. Altern Lab Anim 37:417–425
   PubMed Web of Science ®Google Scholar
• Pessina A, Bonomi A, Cavicchini L, et al. (2010). Prevalidation of the rat CFU-GM assay for in vitro toxicology applications. Altern Lab Anim 38:105–117
   PubMed Web of Science ®Google Scholar
• Pessina A, Croera C, Bayo M, et al. (2004). A methylcellulose microculture assay for the in vitro assessment of drug toxicity on granulocyte/macrophage progenitors (CFU-GM). Altern Lab Anim 32:17–23
   PubMed Web of Science ®Google Scholar
• Pessina A, Malerba F, Gribaldo L. (2005). Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials. Curr Pharm Design 11:1055–1065
   PubMed Web of Science ®Google Scholar
• Pessina A, Parent-Massin D, Albella B, et al. (2009b). Application of human CFU-Mk assay to predict potential thrombocytotoxicity of drugs. Toxicol In Vitro 23:194–200
   PubMed Web of Science ®Google Scholar
• Pessina A, Piccirillo M, Mineo E, et al. (1999). Role of SR-(4987) stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM). Life Sci 65:513–523
   PubMed Web of Science ®Google Scholar
• Piersma AH, Brockbank KG, Ploemacher RE, et al. (1985). Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol 13:237–243
   PubMed Web of Science ®Google Scholar
• Pirson L, Baron F, Meuris N, et al. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells 24:1814–1821
   PubMed Web of Science ®Google Scholar
• Pochampally R. (2008). Colony forming unit assays for MSCs. Methods Mol Biol 449:83–91
   Google Scholar
• Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (New York, N Y) 276:71–74
   PubMed Web of Science ®Google Scholar
• Rahnama R, Wang M, Dang AC, et al. (2013). Cytotoxicity of local anesthetics on human mesenchymal stem cells. J Bone Joint Surg Am 95:132–137
   PubMed Web of Science ®Google Scholar
• Rajesh D, Chinnasamy N, Mitalipov SM, et al. (2007). Differential requirements for hematopoietic commitment between human and rhesus embryonic stem cells. Stem Cells 25:490–499
   PubMed Web of Science ®Google Scholar
• Reece P, Baatjes AJ, Cyr MM, et al. (2013). Toll-like receptor-mediated eosinophil-basophil differentiation: autocrine signalling by granulocyte-macrophage colony-stimulating factor in cord blood haematopoietic progenitors. Immunology 139:256–264
   PubMed Web of Science ®Google Scholar
• Rich IN, Hall KM. (2005). Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Toxicol Sci 87:427–441
   PubMed Web of Science ®Google Scholar
• Rio B, Lautraite S, Parent-Massin D. (1997a). In vitro toxicity of trichothecenes on human erythroblastic progenitors. Hum Exp Toxicol 16:673–679
   PubMed Web of Science ®Google Scholar
• Rio B, Parent-Massin D. (1997). Improvement of erythroblastic progenitor culture for toxicological investigations. Toxicol Methods 7:363–380
   Google Scholar
• Rio B, Parent-Massin D, Lautraite S, Hoellinger H. (1997b). Effects of a diphenyl-ether herbicide, oxyfluorfen, on human BFU-E/CFU-E development and haemoglobin synthesis. Hum Exp Toxicol 16:115–122
   PubMed Web of Science ®Google Scholar
• Roda E, Coccini T, Acerbi D, et al. (2010). Comparative in vitro and ex-vivo myelotoxicity of aflatoxins B1 and M1 on haematopoietic progenitors (BFU-E, CFU-E, and CFU-GM): species-related susceptibility. Toxicol In Vitro 24:217–223
   PubMed Web of Science ®Google Scholar
• Scherzed A, Hackenberg S, Froelich K, et al. (2013). Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro. Toxicol Lett 218:207–214
   PubMed Web of Science ®Google Scholar
• Schmitt TM, Zuniga-Pflucker JC. (2002). Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749–756
   PubMed Web of Science ®Google Scholar
• Song H, Vita M, Sallam H, et al. (2007). Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro. Cancer Chemother Pharmacol 60:841–849
   PubMed Web of Science ®Google Scholar
• Spangrude GJ, Smith L, Uchida N, et al. (1991). Mouse hematopoietic stem cells. Blood 78:1395–1402
   PubMed Web of Science ®Google Scholar
• Steinbock B. (2007). The science, policy, and ethics of stem cell research. Reprod BioMed Online 14:130–136
   Web of Science ®Google Scholar
• Stephenson JR, Axelrad AA, McLeod DL, Shreeve MM. (1971). Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci USA 68:1542–1546
   PubMed Web of Science ®Google Scholar
• Tepperman AD, Curtis JE, McCulloch EA. (1974). Erythropietic colonies in cultures of human marrow. Blood 44:659–669
   PubMed Web of Science ®Google Scholar
• Testa NG, Dexter TM. (1977). Long-term production of erythroid precursor cells (BFU) in bone marrow cultures. Differentiation 9:193–195
   Google Scholar
• The President's Council on Bioethics. (2005). The President's Council on Bioethics Alternative sources of human pluripotent stem cells. A White Paper. Washington (DC): The President's Council on Bioethics
   Google Scholar
• Tian X, Morris JK, Linehan JL, Kaufman DS. (2004). Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 32:1000–1009
   PubMed Web of Science ®Google Scholar
• Van Den Heuvel RL, Leppens H, Schoeters GE. (2001). Use of in vitro assays to assess hematotoxic effects of environmental compounds. Cell Biol Toxicol 17:107–116
   PubMed Web of Science ®Google Scholar
• van Os RP, Dethmers-Ausema B, de Haan G. (2008). In vitro assays for cobblestone area-forming cells, LTC-IC, and CFU-C. Methods Mol Biol 430:143–157
   Google Scholar
• Vemuri MC, Chase LG, Rao MS. (2011). Mesenchymal stem cell assays and applications. Methods Mol Biol 698:3–8
   PubMedGoogle Scholar
• Verma A, Deb DK, Sassano A, et al. (2002). Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I Interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 277:7726–7735
   PubMed Web of Science ®Google Scholar
• Volpe DA, Warren MK. (2003). Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. Toxicol In Vitro 17:271–277
   PubMed Web of Science ®Google Scholar
• Whitlock CA, Witte ON. (1982). Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79:3608–3612
   PubMed Web of Science ®Google Scholar
• Wognum B, Yuan N, Lai B, Miller CL. (2013). Colony forming cell assays for human hematopoietic progenitor cells. Methods Mol Biol 946:267–283
   PubMedGoogle Scholar
• Wolf B, Morgan H, Krieg J, et al. (2012). A whole blood in vitro cytokine release assay with aqueous monoclonal antibody presentation for the prediction of therapeutic protein induced cytokine release syndrome in humans. Cytokine 60:828–837
   PubMed Web of Science ®Google Scholar